Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

Exclusion Criteria

• •Subjects participating in any drug or device clinical investigation within 30 days prior to entry into this study and/or plan to do so during the period of study participation
• •Subjects who are women of childbearing potential (those who are not surgically sterilized or postmenopausal) are excluded from participation in the investigation if they meet any one of the following conditions:
• •* She is currently pregnant
• •* She plans to become pregnant during the study
• •* She is breastfeeding
• •Subjects with any systemic disease currently affecting ocular health or that, in the Investigator's opinion, may have an effect on ocular health during the course of the study
• •Subjects with an active ocular disease
• •Subjects who have had any corneal surgery (e.g., refractive surgery)
• •Subjects who have worn gas-permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last 3 months
• •Subjects who currently wear monovision or toric contact lenses
• •Subjects who are not correctable to 32 letters (0.3 logMAR) with bilateral soft multifocal contact lenses
• •Subjects with an ocular astigmatism \>1.00 D in either eye
• •Subjects with anisometropia (spherical equivalent) \>2.00 D
• •Any "Present" finding during the slit lamp examination that, in the Investigator's opinion, interferes with contact lens wear
• •Any scar or neovascularization within the central 6 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area) that, in the Investigator's opinion, does not interfere with contact lens wear are eligible for this study
• •Subjects who are amblyopic
• •Subjects using any systemic or topical ocular medication that will, in the Investigator's opinion, affect ocular physiology or lens performance
• •Subjects who are allergic to any component in the study care products